Study identifies the predictors of post-coronavirus disease 2019 (COVID-19) syndrome symptoms.
FDA offers more clarity on safety testing for cell therapies
The FDA is providing sponsors of cell therapies with a new draft guidance document on the kinds of safety testing they should perform. The 14-page